Since the glycolytic flux is controlled by mTORC1 (Fig. 3D, E), we examined whether mTOR inhibition, by mimicking the effect of glucose limitation, synergizes with glutaminolysis inhibition in PI3K-altered T-ALL. Here, MTOR is linked to acute lymphoblastic leukemia.